Skip to main content
Id Year Reporting type Decision Issue Request by parties to TEAP Report to be produced
0 2020 Progress updates IV/13 Technical progress update by TEAP and its TOCs Decision IV/13 – Report annually to OEWG on technical progress in reducing the use and emissions of controlled substances and assess the use of alternatives, particularly their direct and indirect global-warming effects 2020 progress report
1 2020 Progress updates XI/17 Technical progress update by TEAP and its TOCs Decision XI/17 – Report on any important new developments on an annual basis 2020 progress report
2 2020 Progress updates XXXI/8 Procedures relevant to nominations to the TEAP and its TOCs Decision XXXI/8 – Provide, as part of its annual progress report, a summary outlining the procedures that the Panel and its technical options committees have undertaken to ensure adherence to the Panel’s terms of reference through clear and transparent procedures, including full consultations with the focal points, in line with the terms of reference, regarding: (a) nomination processes, taking into account the matrix of needed expertise and already available expertise; (b) proposed nominations and appointment decisions; (c) termination of appointments; and (d) replacements 2020 progress report
3 2020 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2020 interim report
4 2020 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2020 final report
5 2020 Thematic reports IV/25 Essential-use nominations Decision IV/25 – Review any submitted nominations and make recommendations in accordance with the criteria established in the decision 2020 progress report (only upon submission of nominations)
6 2020 Thematic reports XXX/7 Halon availability Decision XXX/7 – Submit a report on halon availability, based on the assessment and identification activities set out in paragraphs 2 (a)–(d) of the decision, to the parties in advance of the 42nd meeting of OEWG 2020 progress report
7 2020 Thematic reports XXXI/3 CFC-11 Decision XXXI/3 – Provide the parties with an update to the information provided pursuant to paragraph 2 of decision XXX/3, and provide a report thereon to the 32nd MOP, including any new compelling information that becomes available, as well as providing information on the following: (a) An analysis of CFC 11 banks by geographic location and by market sector; (b) Linkages between the level of production of anhydrous hydrogen fluoride and carbon tetrachloride and unexpected emissions of CFC 11; (c) The types of CFC 11 products, the disposition of any such products, and opportunities and methods to detect such products and potentially recover the associated CFC 11; (d) Identification of possible drivers of illegal production of and trade in CFC 11, such as the availability of technically and economically feasible alternatives to CFC 11 and HCFC-141b and their sustained effectiveness; 2020 task force report
8 2020 Thematic reports XXXI/7 Energy Efficiency Decision XXXI/7 – Prepare a report for consideration by the 32nd MOP addressing any new developments with respect to best practices, availability, accessibility and cost of energy-efficient technologies in the refrigeration, air-conditioning and heat-pump sectors as regards the implementation of the Kigali Amendment to the Montreal Protocol 2020 task force report
9 2020 Thematic reports XXXI/5 Laboratory and analytical uses Decision XXXI/5 – Report in the TEAP quadrennial report on any progress made by parties in reducing their production and consumption of ozone depleting substances for laboratory and analytical uses, on any new alternatives to those uses, and on laboratory standards that can be performed without such substances, on the understanding that, should new compelling information become available, including opportunities for significant reductions in production and consumption, that information should be reported in its annual progress report 2020 progress report (only if new compelling information becomes available)
10 2020 Thematic reports XXXI/6 Process agents Decision XXXI/6 – Report in the TEAP quadrennial reports on any progress made by parties in reducing their use and emissions of controlled substances as process agents and on any new alternatives to such uses, including new production processes and emissions-reduction techniques, on the understanding that should new compelling information become available, that information should be reported in its annual progress report 2020 progress report (only if new compelling information becomes available).
11 2020 Thematic reports XXX/6 Destruction technologies Decision XXX/6 – Assess those destruction technologies listed in annex II to the report of the 30th MOP as not approved or not determined, as well as any other technologies, and to report to the 33rd MOP, with the understanding that, if further information is provided by parties in due time, in particular regarding the destruction of Annex F, group II, substances by cement kilns, the Panel should report to an earlier meeting of OEWG 2020 progress report (only upon provision of further information by parties in due time)
12 2020 Thematic reports XXX/15 Destruction technologies; laboratory and analytical uses; n-propyl bromide; possible new substances Review only if the specific conditions set out in decision XXX/15 are met
13 2020 Periodic assessments XXXI/1 Replenishment study for 2021–2023 Decision XXXI/1 – Prepare a report for submission to the 32nd MOP, and to submit it through the OEWG at its 42nd meeting, to enable the 32nd MOP to adopt a decision on the appropriate level of the 2021–2023 replenishment of the Multilateral Fund Replenishment task force report (2021–2023)
14 2020 Periodic assessments XXXI/1 Replenishment study for 2021–2023 Decision XXXI/1 - Potential additional guidance by OEWG (42nd meeting) in 2020 – Prepare a report on the appropriate level of the 2021–2023 replenishment of the Multilateral Fund Supplement to the replenishment task force report
15 2021 Progress updates IV/13 Technical progress update by TEAP and its TOCs Decision IV/13 – Report annually to OEWG on technical progress in reducing the use and emissions of controlled substances and assess the use of alternatives, particularly their direct and indirect global-warming effects 2021 progress report
16 2021 Progress updates XI/17 Technical progress update by TEAP and its TOCs Decision XI/17 – Report on any important new developments on an annual basis 2021 progress report
17 2021 Progress updates XXXI/8 Procedures relevant to nominations to the TEAP and its TOCs. Decision XXXI/8 – Provide, as part of its annual progress report, a summary outlining the procedures that the Panel and its technical options committees have undertaken to ensure adherence to the Panel’s terms of reference through clear and transparent procedures, including full consultations with the focal points, in line with the terms of reference, regarding: (a) nomination processes, taking into account the matrix of needed expertise and already available expertise; (b) proposed nominations and appointment decisions; (c) termination of appointments; and (d) replacements 2021 progress report
18 2021 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2021 interim report (only upon submission of nominations)
19 2021 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2021 final report (only upon submission of nominations)
20 2021 Thematic reports IV/25 Essential-use nominations Decision IV/25 – Review any submitted nominations and make recommendations in accordance with the criteria established in the decision 2021 progress report (only upon submission of nominations)
21 2021 Thematic reports XXX/6 Destruction technologies Decision XXX/6 – Assess those destruction technologies listed in annex II to the report of the 30th MOP as not approved or not determined, as well as any other technologies, and to report to the 33rd MOP, with the understanding that, if further information is provided by parties in due time, in particular regarding the destruction of Annex F, group II, substances by cement kilns, the Panel should report to an earlier meeting of OEWG 2021 progress report
22 2021 Thematic reports XXXI/5 Laboratory and analytical uses Decision XXXI/5 – Report in the TEAP quadrennial report on any progress made by parties in reducing their production and consumption of ozone depleting substances for laboratory and analytical uses, on any new alternatives to those uses, and on laboratory standards that can be performed without such substances, on the understanding that, should new compelling information become available, including opportunities for significant reductions in production and consumption, that information should be reported in its annual progress report 2021 progress report (only if new compelling information becomes available)
23 2021 Thematic reports XXXI/6 Process agents Decision XXXI/6 – Report in the TEAP quadrennial reports on any progress made by parties in reducing their use and emissions of controlled substances as process agents and on any new alternatives to such uses, including new production processes and emissions-reduction techniques, on the understanding that should new compelling information become available, that information should be reported in its annual progress report 2021 progress report (only if new compelling information becomes available)
24 2021 Thematic reports XXX/15 Process agents; destruction technologies; laboratory and analytical uses; n-propyl bromide; possible new substances Review only if the specific conditions set out in decision XXX/15 are met
25 2022 Progress updates IV/13 Technical progress update by TEAP and its TOCs Decision IV/13 – Report annually to OEWG on technical progress in reducing the use and emissions of controlled substances and assess the use of alternatives, particularly their direct and indirect global-warming effects 2022 progress report
26 2022 Progress updates XI/17 Technical progress update by TEAP and its TOCs Decision XI/17 – Report on any important new developments on an annual basis 2022 progress report
27 2022 Progress updates XXXI/8 Procedures relevant to nominations to the TEAP and its TOCs. Decision XXXI/8 – Provide, as part of its annual progress report, a summary outlining the procedures that the Panel and its technical options committees have undertaken to ensure adherence to the Panel’s terms of reference through clear and transparent procedures, including full consultations with the focal points, in line with the terms of reference, regarding: (a) nomination processes, taking into account the matrix of needed expertise and already available expertise; (b) proposed nominations and appointment decisions; (c) termination of appointments; and (d) replacements 2022 progress report
28 2022 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2022 interim report (only upon submission of nominations)
29 2022 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2022 final report (only upon submission of nominations)
30 2022 Thematic reports IV/25 Essential-use nominations Decision IV/25 – Review any submitted nominations and make recommendations in accordance with the criteria established in the decision 2022 progress report (only upon submission of nominations)
31 2022 Thematic reports XXXI/5 Laboratory and analytical uses Decision XXXI/5 – Report in the TEAP quadrennial report on any progress made by parties in reducing their production and consumption of ozone depleting substances for laboratory and analytical uses, on any new alternatives to those uses, and on laboratory standards that can be performed without such substances, on the understanding that, should new compelling information become available, including opportunities for significant reductions in production and consumption, that information should be reported in its annual progress report TEAP 2022 quadrennial assessment report
32 2022 Thematic reports XXXI/6 Process agents Decision XXXI/6 – Report in the TEAP quadrennial reports on any progress made by parties in reducing their use and emissions of controlled substances as process agents and on any new alternatives to such uses, including new production processes and emissions-reduction techniques, on the understanding that should new compelling information become available, that information should be reported in its annual progress report TEAP 2022 quadrennial assessment reports
33 2022 Thematic reports XXX/15 Process agents; destruction technologies; laboratory and analytical uses; n-propyl bromide; possible new substances Review only if the specific conditions set out in decision XXX/15 are met
34 2022 Periodic assessments XXXI/2 Quadrennial assessment Decision XXXI/2 – Prepare the TEAP 2022 quadrennial assessment TEAP and TOCs 2022 quadrennial assessment reports (6)
35 2022 Periodic assessments XXIX/12 HFCs not listed in Annex F to the Montreal Protocol Decision XXIX/12 – Provide in the quadrennial reports of the assessment panels to be presented to the 35th MOP, in 2023, and every four years thereafter, information on the consumption and production of HFCs not listed in Annex F of the Protocol that have global warming potential no less than the lowest global warming potential of the HFCs listed in Annex F TEAP and TOCs 2022 quadrennial assessment reports (6)
36 2022 Periodic assessments XXX/2 HCFC availability Decision XXX/2 – Provide in its quadrennial reports to be presented to the 35th MOP, in 2023, and to the 39th MOP, in 2027, information on the availability of Annex C, group I, substances, including amounts available from recovery, recycling and reclamation, and best available information on country-level and total known stocks, as well as the availability of alternative options for the applications described in Article 2F, paragraphs 6 (a) and 6 (b) TEAP and TOCs 2022 quadrennial assessment reports (6)
37 2022 Periodic assessments XXVIII/2 Review related to the Kigali Amendment to the Montreal Protocol Decision XXVIII/2, paragraph 4 – Conduct periodic reviews of alternatives to HFCs in 2022 and every five years thereafter, and provide technological and economic assessments of the latest available and emerging alternatives to HFCs (first review) Report on the review of alternatives to HFCs
38 2023 Progress updates IV/13 Technical progress update by TEAP and its TOCs Decision IV/13 – Report annually to OEWG on technical progress in reducing the use and emissions of controlled substances and assess the use of alternatives, particularly their direct and indirect global-warming effects 2023 progress report
39 2023 Progress updates XI/17 Technical progress update by TEAP and its TOCs Decision XI/17 – Report on any important new developments on an annual basis 2023 progress report
40 2023 Progress updates XXXI/8 Procedures relevant to nominations to the TEAP and its TOCs. Decision XXXI/8 – Provide, as part of its annual progress report, a summary outlining the procedures that the Panel and its technical options committees have undertaken to ensure adherence to the Panel’s terms of reference through clear and transparent procedures, including full consultations with the focal points, in line with the terms of reference, regarding: (a) nomination processes, taking into account the matrix of needed expertise and already available expertise; (b) proposed nominations and appointment decisions; (c) termination of appointments; and (d) replacements 2023 progress report
41 2023 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations in accordance with the criteria established in the decision (and other relevant decisions) 2023 interim report (only upon submission of nominations)
42 2023 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations in accordance with the criteria established in the decision (and other relevant decisions) 2023 final report (only upon submission of nominations)
43 2023 Thematic reports IV/25 Essential-use nominations Decision IV/25 – Review any submitted nominations and make recommendations in accordance with the criteria established in the decision 2023 progress report (only upon submission of nominations)
44 2023 Thematic reports XXVIII/2 Review related to the Kigali Amendment to the Montreal Protocol Decision XXVIII/2, paragraph 5 – Conduct a technology review four or five years before 2028 to consider a compliance deferral of two years from the freeze date of 2028 for Article 5, group 2, parties to address growth above a certain threshold in several sectors Report on technology review
45 2023 Thematic reports XXXI/5 Laboratory and analytical uses Decision XXXI/5 – Report in the TEAP quadrennial report on any progress made by parties in reducing their production and consumption of ozone depleting substances for laboratory and analytical uses, on any new alternatives to those uses, and on laboratory standards that can be performed without such substances, on the understanding that, should new compelling information become available, including opportunities for significant reductions in production and consumption, that information should be reported in its annual progress report 2023 progress report (only if new compelling information becomes available)
46 2023 Thematic reports XXXI/6 Process agents Decision XXXI/6 – Report in the TEAP quadrennial reports on any progress made by parties in reducing their use and emissions of controlled substances as process agents and on any new alternatives to such uses, including new production processes and emissions-reduction techniques, on the understanding that should new compelling information become available, that information should be reported in its annual progress report 2023 progress report (only if new compelling information becomes available)
47 2023 Thematic reports XXX/15 Process agents; destruction technologies; laboratory and analytical uses; n-propyl bromide; possible new substances Review only if the specific conditions set out in decision XXX/15 are met
48 2023 Periodic assessments Replenishment study for 2024–2026 Expected decision at the 34th MOP, in 2022, and potential additional guidance by OEWG (45th meeting) in 2023 – Prepare a report on the appropriate level of the 2024–2026 replenishment of the Multilateral Fund Replenishment task force report (2024–2026)
49 2023 Periodic assessments Replenishment study for 2024–2026 Expected decision at the 34th MOP, in 2022, and potential additional guidance by OEWG (45th meeting) in 2023 – Prepare a report on the appropriate level of the 2024–2026 replenishment of the Multilateral Fund Supplement to the replenishment task force report
50 2023 Periodic assessments Quadrennial assessment Expected decision at the 31st MOP, in 2019 – Prepare the assessment panels’ synthesis report 2022 quadrennial assessment synthesis report
51 2024 Progress updates IV/13 Technical progress update by TEAP and its TOCs Decision IV/13 – Report annually to OEWG on technical progress in reducing the use and emissions of controlled substances and assess the use of alternatives, particularly their direct and indirect global-warming effects 2024 progress report
52 2024 Progress updates XI/17 Technical progress update by TEAP and its TOCs Decision XI/17 – Report on any important new developments on an annual basis 2024 progress report
53 2024 Progress updates XXXI/8 Procedures relevant to nominations to the TEAP and its TOCs. Decision XXXI/8 – Provide, as part of its annual progress report, a summary outlining the procedures that the Panel and its technical options committees have undertaken to ensure adherence to the Panel’s terms of reference through clear and transparent procedures, including full consultations with the focal points, in line with the terms of reference, regarding: (a) nomination processes, taking into account the matrix of needed expertise and already available expertise; (b) proposed nominations and appointment decisions; (c) termination of appointments; and (d) replacements 2024 progress report
54 2024 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2024 interim report (only upon submission of nominations)
55 2024 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2024 final report (only upon submission of nominations)
56 2024 Thematic reports IV/25 Essential-use nominations Decision IV/25 – Review any submitted nominations and make recommendations in accordance with the criteria established in the decision 2024 progress report (only upon submission of nominations)
57 2024 Thematic reports XXVIII/2 Review related to the Kigali Amendment to the Montreal Protocol Decision XXVIII/2, paragraph 5 – Conduct a technology review four or five years before 2028 to consider a compliance deferral of two years from the freeze date of 2028 for Article 5, group 2, parties to address growth above a certain threshold in several sectors Report on technology review
58 2024 Thematic reports XXXI/5 Laboratory and analytical uses Decision XXXI/5 – Report in the TEAP quadrennial report on any progress made by parties in reducing their production and consumption of ozone depleting substances for laboratory and analytical uses, on any new alternatives to those uses, and on laboratory standards that can be performed without such substances, on the understanding that, should new compelling information become available, including opportunities for significant reductions in production and consumption, that information should be reported in its annual progress report 2024 progress report (only if new compelling information becomes available)
59 2024 Thematic reports XXXI/6 Process agents Decision XXXI/6 – Report in the TEAP quadrennial reports on any progress made by parties in reducing their use and emissions of controlled substances as process agents and on any new alternatives to such uses, including new production processes and emissions-reduction techniques, on the understanding that should new compelling information become available, that information should be reported in its annual progress report 2024 progress report (only if new compelling information becomes available)
60 2024 Thematic reports XXX/15 Process agents; destruction technologies; laboratory and analytical uses; n-propyl bromide; possible new substances Review only if the specific conditions set out in decision XXX/15 are met
61 2025 Progress updates IV/13 Technical progress update by TEAP and its TOCs Decision IV/13 – Report annually to OEWG on technical progress in reducing the use and emissions of controlled substances and assess the use of alternatives, particularly their direct and indirect global-warming effects 2025 progress report
62 2025 Progress updates XI/17 Technical progress update by TEAP and its TOCs Decision XI/17 – Report on any important new developments on an annual basis 2025 progress report
63 2025 Progress updates XXXI/8 Procedures relevant to nominations to the TEAP and its TOCs. Decision XXXI/8 – Provide, as part of its annual progress report, a summary outlining the procedures that the Panel and its technical options committees have undertaken to ensure adherence to the Panel’s terms of reference through clear and transparent procedures, including full consultations with the focal points, in line with the terms of reference, regarding: (a) nomination processes, taking into account the matrix of needed expertise and already available expertise; (b) proposed nominations and appointment decisions; (c) termination of appointments; and (d) replacements 2025 progress report
64 2025 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2025 interim report (only upon submission of nominations)
65 2025 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2025 final report (only upon submission of nominations)
66 2025 Thematic reports IV/25 Essential-use nominations Decision IV/25 – Review any submitted nominations and make recommendations in accordance with the criteria established in the decision 2025 progress report (only upon submission of nominations)
67 2025 Thematic reports XXXI/5 Laboratory and analytical uses Decision XXXI/5 – Report in the TEAP quadrennial report on any progress made by parties in reducing their production and consumption of ozone depleting substances for laboratory and analytical uses, on any new alternatives to those uses, and on laboratory standards that can be performed without such substances, on the understanding that, should new compelling information become available, including opportunities for significant reductions in production and consumption, that information should be reported in its annual progress report 2025 progress report (only if new compelling information becomes available)
68 2025 Thematic reports XXXI/6 Process agents Decision XXXI/6 – Report in the TEAP quadrennial reports on any progress made by parties in reducing their use and emissions of controlled substances as process agents and on any new alternatives to such uses, including new production processes and emissions-reduction techniques, on the understanding that should new compelling information become available, that information should be reported in its annual progress report 2025 progress report (only if new compelling information becomes available)
69 2025 Thematic reports XXX/15 Process agents; destruction technologies; laboratory and analytical uses; n-propyl bromide; possible new substances Review only if the specific conditions set out in decision XXX/15 are met
70 2026 Progress updates IV/13 Technical progress update by TEAP and its TOCs Decision IV/13 – Report annually to OEWG on technical progress in reducing the use and emissions of controlled substances and assess the use of alternatives, particularly their direct and indirect global-warming effects 2026 progress report
71 2026 Progress updates XI/17 Technical progress update by TEAP and its TOCs Decision XI/17 – Report on any important new developments on an annual basis 2026 progress report
72 2026 Progress updates XXXI/8 Procedures relevant to nominations to the TEAP and its TOCs. Decision XXXI/8 – Provide, as part of its annual progress report, a summary outlining the procedures that the Panel and its technical options committees have undertaken to ensure adherence to the Panel’s terms of reference through clear and transparent procedures, including full consultations with the focal points, in line with the terms of reference, regarding: (a) nomination processes, taking into account the matrix of needed expertise and already available expertise; (b) proposed nominations and appointment decisions; (c) termination of appointments; and (d) replacements 2026 progress report
73 2026 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2026 interim report (only upon submission of nominations)
74 2026 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2026 final report (only upon submission of nominations)
75 2026 Thematic reports IV/25 Essential-use nominations Decision IV/25 – Review any submitted nominations and make recommendations in accordance with the criteria established in the decision 2026 progress report (only upon submission of nominations)
76 2026 Thematic reports XXXI/5 Laboratory and analytical uses Decision XXXI/5 – Report in the TEAP quadrennial report on any progress made by parties in reducing their production and consumption of ozone depleting substances for laboratory and analytical uses, on any new alternatives to those uses, and on laboratory standards that can be performed without such substances, on the understanding that, should new compelling information become available, including opportunities for significant reductions in production and consumption, that information should be reported in its annual progress report TEAP 2026 quadrennial assessment report
77 2026 Thematic reports XXXI/6 Process agents Decision XXXI/6 – Report in the TEAP quadrennial reports on any progress made by parties in reducing their use and emissions of controlled substances as process agents and on any new alternatives to such uses, including new production processes and emissions-reduction techniques, on the understanding that should new compelling information become available, that information should be reported in its annual progress report TEAP 2026 quadrennial assessment reports
78 2026 Thematic reports XXX/15 Process agents; destruction technologies; laboratory and analytical uses; n-propyl bromide; possible new substances Review only if the specific conditions set out in decision XXX/15 are met
79 2026 Periodic assessments Replenishment study for 2027–2029 Expected decision at the 37th MOP, in 2025, and potential additional guidance by OEWG (48th meeting) in 2026 – Prepare a report on the appropriate level of the 2027–2029 replenishment of the Multilateral Fund Replenishment task force report (2027–2029)
80 2026 Periodic assessments Replenishment study for 2027–2029 Expected decision at the 37th MOP, in 2025, and potential additional guidance by OEWG (48th meeting) in 2026 – Prepare a report on the appropriate level of the 2027–2029 replenishment of the Multilateral Fund Supplement to the replenishment task force report
81 2026 Periodic assessments Quadrennial assessment Expected decision at the 35th MOP, in 2023 – Prepare the TEAP 2026 quadrennial assessment TEAP and TOCs 2026 quadrennial assessment reports (6)
82 2026 Periodic assessments XXIX/12 HFCs not listed in Annex F of the Montreal Protocol Decision XXIX/12 – Provide in the quadrennial reports of the assessment panels to be presented to the 35th MOP, in 2023, and every four years thereafter, information on the consumption and production of HFCs not listed in Annex F of the Protocol that have global warming potential no less than the lowest global warming potential of the HFCs listed in Annex F TEAP and TOCs 2026 quadrennial assessment reports (6)
83 2026 Periodic assessments XXX/2 HCFC availability Decision XXX/2 – Provide in its quadrennial reports to be presented to the 35th MOP, in 2023, and to the 39th MOP, in 2027, information on the availability of Annex C, group I, substances, including amounts available from recovery, recycling and reclamation, and best available information on country-level and total known stocks, as well as the availability of alternative options for the applications described in Article 2F, paragraphs 6 (a) and 6 (b) TEAP and TOCs 2026 quadrennial assessment reports (6)
84 2027 Progress updates IV/13 Technical progress update by TEAP and its TOCs Decision IV/13 – Report annually to OEWG on technical progress in reducing the use and emissions of controlled substances and assess the use of alternatives, particularly their direct and indirect global-warming effects 2027 progress report
85 2027 Progress updates XI/17 Technical progress update by TEAP and its TOCs Decision XI/17 – Report on any important new developments on an annual basis 2027 progress report
86 2027 Progress updates XXXI/8 Procedures relevant to nominations to the TEAP and its TOCs. Decision XXXI/8 – Provide, as part of its annual progress report, a summary outlining the procedures that the Panel and its technical options committees have undertaken to ensure adherence to the Panel’s terms of reference through clear and transparent procedures, including full consultations with the focal points, in line with the terms of reference, regarding: (a) nomination processes, taking into account the matrix of needed expertise and already available expertise; (b) proposed nominations and appointment decisions; (c) termination of appointments; and (d) replacements 2027 progress report
87 2027 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2027 interim report (only upon submission of nominations)
88 2027 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2027 final report (only upon submission of nominations)
89 2027 Thematic reports IV/25 Essential-use nominations Decision IV/25 – Review any submitted nominations and make recommendations in accordance with the criteria established in the decision 2027 progress report (only upon submission of nominations)
90 2027 Thematic reports XXXI/5 Laboratory and analytical uses Decision XXXI/5 – Report in the TEAP quadrennial report on any progress made by parties in reducing their production and consumption of ozone depleting substances for laboratory and analytical uses, on any new alternatives to those uses, and on laboratory standards that can be performed without such substances, on the understanding that, should new compelling information become available, including opportunities for significant reductions in production and consumption, that information should be reported in its annual progress report 2027 progress report (only if new compelling information becomes available)
91 2027 Thematic reports XXXI/6 Process agents Decision XXXI/6 – Report in the TEAP quadrennial reports on any progress made by parties in reducing their use and emissions of controlled substances as process agents and on any new alternatives to such uses, including new production processes and emissions-reduction techniques, on the understanding that should new compelling information become available, that information should be reported in its annual progress report 2027 progress report (only if new compelling information becomes available)
92 2027 Thematic reports XXX/15 Process agents; destruction technologies; laboratory and analytical uses; n-propyl bromide; possible new substances Review only if the specific conditions set out in decision XXX/15 are met
93 2027 Periodic assessments Quadrennial assessment Expected decision at the 35th MOP, in 2023 – Prepare the assessment panels’ synthesis report 2026 quadrennial assessment synthesis report
94 2027 Periodic assessments XXVIII/2 Review related to the Kigali Amendment to the Montreal Protocol Decision XXVIII/2, paragraph 4 – Conduct periodic reviews of alternatives to HFCs in 2022 and every five years thereafter, and provide technological and economic assessments of the latest available and emerging alternatives to HFCs (second review) Report on review of alternatives to HFCs
95 2028 Progress updates IV/13 Technical progress update by TEAP and its TOCs Decision IV/13 – Report annually to OEWG on technical progress in reducing the use and emissions of controlled substances and assess the use of alternatives, particularly their direct and indirect global-warming effects 2028 progress report
96 2028 Progress updates XI/17 Technical progress update by TEAP and its TOCs Decision XI/17 – Report on any important new developments on an annual basis 2028 progress report
97 2028 Progress updates XXXI/8 Procedures relevant to nominations to the TEAP and its TOCs. Decision XXXI/8 – Provide, as part of its annual progress report, a summary outlining the procedures that the Panel and its technical options committees have undertaken to ensure adherence to the Panel’s terms of reference through clear and transparent procedures, including full consultations with the focal points, in line with the terms of reference, regarding: (a) nomination processes, taking into account the matrix of needed expertise and already available expertise; (b) proposed nominations and appointment decisions; (c) termination of appointments; and (d) replacements 2028 progress report
98 2028 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2028 interim report (only upon submission of nominations)
99 2028 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2028 final report (only upon submission of nominations)
100 2028 Thematic reports IV/25 Essential-use nominations Decision IV/25 – Review any submitted nominations and make recommendations in accordance with the criteria established in the decision 2028 progress report (only upon submission of nominations)
101 2028 Thematic reports XXXI/5 Laboratory and analytical uses Decision XXXI/5 – Report in the TEAP quadrennial report on any progress made by parties in reducing their production and consumption of ozone depleting substances for laboratory and analytical uses, on any new alternatives to those uses, and on laboratory standards that can be performed without such substances, on the understanding that, should new compelling information become available, including opportunities for significant reductions in production and consumption, that information should be reported in its annual progress report 2028 progress report (only if new compelling information becomes available)
102 2028 Thematic reports XXXI/6 Process agents Decision XXXI/6 – Report in the TEAP quadrennial reports on any progress made by parties in reducing their use and emissions of controlled substances as process agents and on any new alternatives to such uses, including new production processes and emissions-reduction techniques, on the understanding that should new compelling information become available, that information should be reported in its annual progress report 2028 progress report (only if new compelling information becomes available)
103 2028 Thematic reports XXX/15 Process agents; destruction technologies; laboratory and analytical uses; n-propyl bromide; possible new substances Review only if the specific conditions set out in decision XXX/15 are met
104 2028 Periodic assessments XXVIII/2 Review related to the Kigali Amendment to the Montreal Protocol Decision XXVIII/2, paragraphs 32 and 33 – Periodically assess the suitability of HFC alternatives for use at high ambient temperatures, starting four years from the HFC freeze date and every four years thereafter (first review) Assessment of high-ambient-temperature HFC alternatives
105 2029 Progress updates IV/13 Technical progress update by TEAP and its TOCs Decision IV/13 – Report annually to OEWG on technical progress in reducing the use and emissions of controlled substances and assess the use of alternatives, particularly their direct and indirect global-warming effects 2029 progress report
106 2029 Progress updates XI/17 Technical progress update by TEAP and its TOCs Decision XI/17 – Report on any important new developments on an annual basis 2029 progress report
107 2029 Progress updates XXXI/8 Procedures relevant to nominations to the TEAP and its TOCs. Decision XXXI/8 – Provide, as part of its annual progress report, a summary outlining the procedures that the Panel and its technical options committees have undertaken to ensure adherence to the Panel’s terms of reference through clear and transparent procedures, including full consultations with the focal points, in line with the terms of reference, regarding: (a) nomination processes, taking into account the matrix of needed expertise and already available expertise; (b) proposed nominations and appointment decisions; (c) termination of appointments; and (d) replacements 2029 progress report
108 2029 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2029 interim report (only upon submission of nominations)
109 2029 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2029 final report (only upon submission of nominations)
110 2029 Thematic reports IV/25 Essential-use nominations Decision IV/25 – Review any submitted nominations and make recommendations in accordance with the criteria established in the decision 2029 progress report (only upon submission of nominations)
111 2029 Thematic reports XXXI/5 Laboratory and analytical uses Decision XXXI/5 – Report in the TEAP quadrennial report on any progress made by parties in reducing their production and consumption of ozone depleting substances for laboratory and analytical uses, on any new alternatives to those uses, and on laboratory standards that can be performed without such substances, on the understanding that, should new compelling information become available, including opportunities for significant reductions in production and consumption, that information should be reported in its annual progress report 2029 progress report (only if new compelling information becomes available)
112 2029 Thematic reports XXXI/6 Process agents Decision XXXI/6 – Report in the TEAP quadrennial reports on any progress made by parties in reducing their use and emissions of controlled substances as process agents and on any new alternatives to such uses, including new production processes and emissions-reduction techniques, on the understanding that should new compelling information become available, that information should be reported in its annual progress report 2029 progress report (only if new compelling information becomes available)
113 2029 Thematic reports XXX/15 Process agents; destruction technologies; laboratory and analytical uses; n-propyl bromide; possible new substances Review only if the specific conditions set out in decision XXX/15 are met
114 2029 Periodic assessments Replenishment study for 2030–2032 Expected decision at the 40th MOP, in 2028, and potential additional guidance by OEWG (51st meeting) in 2029 – Prepare a report on the appropriate level of the 2030–2032 replenishment of the Multilateral Fund Replenishment task force report (2030–2032)
115 2029 Periodic assessments Replenishment study for 2030–2032 Expected decision at the 40th MOP, in 2028, and potential additional guidance by OEWG (51st meeting) in 2029 – Prepare a report on the appropriate level of the 2030–2032 replenishment of the Multilateral Fund Supplement to the replenishment task force report
116 2030 Progress updates IV/13 Technical progress update by TEAP and its TOCs Decision IV/13 – Report annually to OEWG on technical progress in reducing the use and emissions of controlled substances and assess the use of alternatives, particularly their direct and indirect global-warming effects 2030 progress report
117 2030 Progress updates XI/17 Technical progress update by TEAP and its TOCs Decision XI/17 – Report on any important new developments on an annual basis 2030 progress report
118 2030 Progress updates XXXI/8 Procedures relevant to nominations to the TEAP and its TOCs. Decision XXXI/8 – Provide, as part of its annual progress report, a summary outlining the procedures that the Panel and its technical options committees have undertaken to ensure adherence to the Panel’s terms of reference through clear and transparent procedures, including full consultations with the focal points, in line with the terms of reference, regarding: (a) nomination processes, taking into account the matrix of needed expertise and already available expertise; (b) proposed nominations and appointment decisions; (c) termination of appointments; and (d) replacements 2030 progress report
119 2030 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2030 interim report (only upon submission of nominations)
120 2030 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2030 final report (only upon submission of nominations)
121 2030 Thematic reports IV/25 Essential-use nominations Decision IV/25 – Review any submitted nominations and make recommendations in accordance with the criteria established in the decision 2030 progress report (only upon submission of nominations)
122 2030 Thematic reports XXXI/5 Laboratory and analytical uses Decision XXXI/5 – Report in the TEAP quadrennial report on any progress made by parties in reducing their production and consumption of ozone depleting substances for laboratory and analytical uses, on any new alternatives to those uses, and on laboratory standards that can be performed without such substances, on the understanding that, should new compelling information become available, including opportunities for significant reductions in production and consumption, that information should be reported in its annual progress report TEAP 2030 quadrennial assessment report
123 2030 Thematic reports XXXI/6 Process agents Decision XXXI/6 – Report in the TEAP quadrennial reports on any progress made by parties in reducing their use and emissions of controlled substances as process agents and on any new alternatives to such uses, including new production processes and emissions-reduction techniques, on the understanding that should new compelling information become available, that information should be reported in its annual progress report TEAP 2030 quadrennial assessment report
124 2030 Thematic reports XXX/15 Process agents; destruction technologies; laboratory and analytical uses; n-propyl bromide; possible new substances Review only if the specific conditions set out in decision XXX/15 are met
125 2030 Periodic assessments Quadrennial assessment Expected decision at the 39th MOP, in 2027 - Prepare the TEAP 2030 quadrennial assessment TEAP and TOCs 2030 quadrennial assessment reports (6)
126 2030 Periodic assessments XXIX/12 HFCs not listed in Annex F of the Montreal Protocol Decision XXIX/12 – Provide in the quadrennial reports of the assessment panels to be presented to the 35th MOP, in 2023, and every four years thereafter, information on the consumption and production of HFCs not listed in Annex F of the Protocol that have global warming potential no less than the lowest global warming potential of the HFCs listed in Annex F TEAP and TOCs 2030 quadrennial assessment reports (6)
1 Provisions related to laboratory and analytical use are superceded by decision XXXI/5. The process of dealing with possible new substances is set out in decision IX/24.
2 Reports to be produced on the listed issues are not indicated herein given that the time at which the respective conditions set out in decision XXX/15 will be met is not known.
3 The provisions of decision XXX/15 regarding process agents and laboratory and analytical uses are superceded by decisions XXXI/6 and XXXI/5, respectively. The process of dealing with possible new substances is set out in decision IX/24.
4 In case the review in response to decision XXVIII/2, para. 5, is conducted five years before 2028.
5 In case the review in response to decision XXVIII/2, para. 5, is conducted four years before 2028.